| 000 | 01691 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511193114.0 | ||
| 264 | 0 | _c19920618 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0895-7061 | ||
| 024 | 7 |
_a10.1093/ajh/5.5.257 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGall, M A | |
| 245 | 0 | 0 |
_aPlacebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension. _h[electronic resource] |
| 260 |
_bAmerican journal of hypertension _cMay 1992 |
||
| 300 |
_a257-65 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCaptopril _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdiet therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xadverse effects |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetoprolol _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aRossing, P | |
| 700 | 1 | _aSkøtt, P | |
| 700 | 1 | _aHommel, E | |
| 700 | 1 | _aMathiesen, E R | |
| 700 | 1 | _aGerdes, L U | |
| 700 | 1 | _aLauritzen, M | |
| 700 | 1 | _aVølund, A | |
| 700 | 1 | _aFaergeman, O | |
| 700 | 1 | _aBeck-Nielsen, H | |
| 773 | 0 |
_tAmerican journal of hypertension _gvol. 5 _gno. 5 Pt 1 _gp. 257-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ajh/5.5.257 _zAvailable from publisher's website |
| 999 |
_c1587496 _d1587496 |
||